Is Coronavirus Disease 2019 (COVID-19) seen less in countries more exposed to Malaria?

MeSH terms

• Africa South of the Sahara / epidemiology
• Anti-Inflammatory Agents / adverse effects
• Anti-Inflammatory Agents / pharmacology
• Anti-Inflammatory Agents / therapeutic use
• Antigen Presentation / drug effects
• Antimalarials / pharmacology*
• Antimalarials / therapeutic use
• Antiviral Agents / adverse effects
• Antiviral Agents / pharmacology*
• Antiviral Agents / therapeutic use
• Betacoronavirus* / drug effects
• Betacoronavirus* / genetics
• Betacoronavirus* / physiology
• COVID-19
• COVID-19 Drug Treatment
• Chloroquine / adverse effects
• Chloroquine / pharmacology*
• Chloroquine / therapeutic use
• Coronaviridae / genetics
• Coronavirus Infections / drug therapy
• Coronavirus Infections / epidemiology*
• Coronavirus Infections / prevention & control
• Drug Utilization / trends
• Humans
• Hydroxychloroquine / adverse effects
• Hydroxychloroquine / pharmacology*
• Hydroxychloroquine / therapeutic use
• Immunologic Factors / adverse effects
• Immunologic Factors / pharmacology
• Immunologic Factors / therapeutic use
• Macrophages / drug effects
• Macrophages / immunology
• Malaria, Falciparum / drug therapy
• Malaria, Falciparum / epidemiology*
• Malaria, Falciparum / prevention & control
• Pandemics* / prevention & control
• Pneumonia, Viral / drug therapy
• Pneumonia, Viral / epidemiology*
• Pneumonia, Viral / prevention & control
• SARS-CoV-2
• Virus Replication / drug effects